XmAb-541

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameXmAb-541

Drug Alias NameXmAb541XmAb-541

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsAnti-CLDN6 +[4]

TargetsClaudin 6T cell surface glycoprotein CD3

Therapy Area/IndicationsEndometrial NeoplasmsOvarian NeoplasmsGerminoma +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesXencor Inc

China Registration ClassN/A

Develop Information

Active CompaniesXencor Inc

Inactive CompaniesN/A

Active IndicationsEndometrial NeoplasmsOvarian NeoplasmsGerminoma +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A